Research Article
Mitochondrial DNA Haplogroups and Susceptibility to Prostate Cancer in a Colombian Population
Table 3
Frequencies (%) of mitochondrial DNA haplogroups in patients and controls.
| Haplogroup | Patients with prostate cancer
| Control group
| P value1 |
| A | 41.1 () | 42.1 () | 0.84 | B | 22.0 () | 21.4 () | 0.89 | C | 11.9 () | 11.4 () | 0.89 | D | 6.0 () | 10.0 () | 0.18 | H | 5.5 () | 8.0 () | 0.37 | HV | 1.9 () | 0.8 () | 0.40 | L | 6.6 () | 2.1 () | 0.06 | J | 0.7 () | 0.0 () | 0.36 | K | 0.0 () | 0.7 () | 0.27 | M | 0.6 () | 0.0 () | 0.36 | N | 0.0 () | 1.4 () | 0.12 | T | 1.9 () | 0.0 () | 0.11 | U | 2.4 () | 2.1 () | 0.88 |
|
|
value: Pearson chi-square or Fisher’s exact tests.
|